Sphera Funds Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-317,000
Closed -$7.57M 109
2019
Q4
$7.57M Buy
317,000
+57,000
+22% +$1.57M 0.62% 34
2019
Q3
$6.97M Buy
+260,000
New +$7.3M 1.08% 26
2019
Q1
Sell
-147,000
Closed -$2.87M 133
2018
Q4
$2.87M Hold
147,000
0.32% 65
2018
Q3
$3.92M Buy
147,000
+27,000
+23% +$882K 0.45% 68
2018
Q2
$1.39M Buy
+120,000
New +$4.59M 0.19% 87
2018
Q1
Sell
-210,000
Closed -$9.22M 157
2017
Q4
$10.2M Buy
210,000
+65,000
+45% +$3.29M 1.2% 16
2017
Q3
$7.83M Buy
145,000
+105,000
+263% +$6.16M 1.12% 18
2017
Q2
$2.25M Buy
+40,000
New +$1.6M 0.38% 77
2017
Q1
Sell
-100,000
Closed -$2.24M 132
2016
Q4
$2.24M Buy
+100,000
New +$1.95M 0.57% 51
2016
Q2
Sell
-50,000
Closed -$1.02M 119
2016
Q1
$1.02M Sell
50,000
-35,500
-42% -$1.13M 0.22% 80
2015
Q4
$4.4M Sell
85,500
-9,500
-10% -$461K 0.64% 27
2015
Q3
$4.05M Buy
95,000
+9,000
+10% +$434K 0.52% 38
2015
Q2
$3.92M Sell
86,000
-14,023
-14% -$564K 0.38% 59
2015
Q1
$3.8M Buy
100,023
+30,023
+43% +$1.03M 0.4% 62
2014
Q4
$1.98M Buy
+70,000
New +$1.95M 0.34% 90
2014
Q1
Sell
-63,471
Closed -$1.63M 140
2013
Q4
$1.63M Buy
+63,471
New +$1.54M 0.46% 58

Other funds holding PTLA

Sphera Funds Management's PTLA Position: Q1 2020 in Review

Sphera Funds Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 317,000 shares — an estimated $7.57M sold.

Sphera Funds Management first reported a position in PTLA in Q4 2013 and held it in 16 quarters. The position peaked at $10.2M in Q4 2017. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Sphera Funds Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Sphera Funds Management sold 317,000 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $7.57M.
  • Sphera Funds Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 16 quarters.
  • Sphera Funds Management's Portola Pharmaceuticals, Inc. position peaked at $10.2M in Q4 2017.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Sphera Funds Management's 13F filing for Q1 2020, filed 14 May 2020.